Bioventus (BVS) Other Accumulated Expenses (2020 - 2026)

Bioventus' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• Quarterly Other Accumulated Expenses fell 4.57% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 4.57% YoY) and the FY2025 annual result came in at $4.2 million, up 7.48% from the prior year.
• Other Accumulated Expenses was $4.2 million for Q1 2026 at Bioventus, down from $4.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $4.8 million in Q4 2023 and bottomed at $3.5 million in Q4 2022.
• A 5-year average of $4.2 million and a median of $4.2 million in 2025 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses sank 61.36% — and 2023, when it jumped 35.38%.
• Bioventus' Other Accumulated Expenses stood at $3.6 million in 2022, then jumped by 33.52% to $4.8 million in 2023, then declined by 18.67% to $3.9 million in 2024, then gained by 7.48% to $4.2 million in 2025, then slipped by 1.19% to $4.2 million in 2026.
• Business Quant data shows BVS's Other Accumulated Expenses at $4.2 million in Q1 2026, $4.2 million in Q4 2025, and $4.4 million in Q3 2025.